Literature DB >> 1870944

Antiviral drugs.

E H Wiltink1, R Janknegt.   

Abstract

There are only a limited number of effective, non-toxic antiviral drugs for clinical use, whereas there is a great need for such drugs. Especially for the treatment of patients infected with the human immuno-deficiency virus (HIV) anti-HIV drugs are required. At the same time viral infections secondary to AIDS cannot yet be treated effectively. An increasing problem is the development of virus strains resistant to the available drugs. At this moment a great effort is made in the research for new antiviral drugs. In this article the available antiviral drugs are reviewed. Their antiviral properties, mechanism of action, clinical use, pharmacokinetic properties and side-effects are discussed. Some attention is paid to the future directions in the search for new anti-HIV drugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870944     DOI: 10.1007/bf01974982

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  41 in total

1.  Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.

Authors:  E Dournon; S Matheron; W Rozenbaum; S Gharakhanian; C Michon; P M Girard; C Perronne; D Salmon; P De Truchis; C Leport
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

2.  Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.

Authors:  A Erice; S Chou; K K Biron; S C Stanat; H H Balfour; M C Jordan
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

Review 3.  Interferons.

Authors:  F R Balkwill
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

Review 4.  Antiviral therapy.

Authors:  M J Wood; A M Geddes
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

5.  Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

Authors:  M A Jacobson; J J O'Donnell; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

6.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

7.  Antiviral agents.

Authors:  P E Hermans; F R Cockerill
Journal:  Mayo Clin Proc       Date:  1987-12       Impact factor: 7.616

Review 8.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

Review 9.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 10.  Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

Authors:  B Oberg
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

View more
  1 in total

Review 1.  Future prospects in antiviral therapy.

Authors:  E H Wiltink
Journal:  Pharm Weekbl Sci       Date:  1992-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.